Predicting mortality and morbidity for scleroderma patients, either of the limited or diffusive cutaneous systemic sclerosis subtypes (lcSSc and…
Maureen Newman
Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Maureen Newman
A diagnosis of systemic sclerosis (SSc) can be extremely stressful for patients, and it is important that patients receive…
Although women have a greater risk for systemic sclerosis (SSc), they may actually experience a lesser degree of symptoms.
Most of the time, systemic sclerosis is associated with adulthood. However, juvenile systemic sclerosis (jSSc) is just as severe,…
Systemic sclerosis, often characterized by thickened skin and connective tissue, may be a result of increased signaling pathways. According…
In 90% of all scleroderma patients, gastrointestinal (GI) tract problems lead to uncomfortable and dangerous complications. Malnutrition, nausea, vomiting,…
Scleroderma can often be a side effect of chronic graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation, as…
Nonsense mutation Duchenne muscular dystrophy (nmDMD) patients living in the European Union may soon experience relief from their condition due…